Unbelievable that this company is still going. A $51m loss this FY just passed, sure $20 something million was impairment, but direct production costs are higher than selling price in a very competitive market, and falling prices.
Interesting all ASX cannabis stocks have an Auditors report along the lines of doubtful if the remain a viable concern, this is strike two for Can Not
Ann: Cann Group Receives $1 Million Advance on R&D Refund, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.118M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 69958 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 12155 | 1 |
View Market Depth
| Last trade - 09.27am 31/07/2025 (20 minute delay) ? |
| CAN (ASX) Chart |
Day chart unavailable